Bio€quity Europe 2019 will congregate the international biotechnology ecosystem in Barcelona from May 20th to 21st. For the first time ever, the Catalan capital will host the sector’s most important event; a platform for investors, venture capital firms, life sciences companies seeking capital and pharmaceutical licensing professionals.
Bio€quity Europe is co-organized by BioCentury and EBD Group with the support of the Host Regional Committee, which is comprised of four organizations: Catalonia Trade & Investment, Biocat, Ysios Capital, and CataloniaBio & HealthTech. You can register to attend Bio€quity Europe 2019 here.
Now celebrating its 20th edition, Bio€quity Europe has showcased, in all its meetings, more than 800 leading European companies to thousands of investment and pharma business development professionals. Last edition gathered more than 550 delegates from 26 countries in Ghent (Belgium).
In the coming edition, Catalonia will have an outstanding opportunity to present its vibrant local life sciences sector.
Catalonia, at the forefront in life sciences
With 871 companies and 89 research organizations in the field of life sciences, Catalonia has more pharmaceutical companies per capita than any other European country. At the same time, it ranks third in Biotech companies and is fourth in the ranking of Medtech companies per capita. The life science industry turnover (€15,956 million euros in 2017) accounts for 7.1% of GDP in Catalonia and the sector employs 46,676 people.
Although Catalonia represents only 1.5% of the EU population, Catalan researchers produce 3.7% of all scientific production in Europe and 1% of the world’s. It is home to local companies such as Grifols, Almirall, Esteve, Lacer, Bioiberica, Reig Jofre and Uriach, whilst multinationals such as Novartis, Roche, Sanofi, Bayer, Boehringer Ingelheim or B. Braun have headquarters here.
A booming startup sector
Barcelona is Southern Europe’s most dynamic startup ecosystem, being home to over 1,300 startups. Life sciences is the second field with the highest number of startups, right after Industry 4.0. In addition, Biotech & Pharma startups, together with Medtech and Fintech, attract higher investments than the rest of the sectors.
In fact, two Catalan startups from the life sciences sector ranked amongst the top 5 rounds of investment in 2018: Minoryx, which closed a €21.3 million round, and Abac, which secured a €16 million euro round.
A magnet for foreign investors
The investment attraction capacity of Catalonia in the field of life sciences is extremely high. Between 2013 and 2017, Catalonia attracted 28 foreign investment projects in this sector, creating 1,543 jobs and representing an investment of 670 million euros. With 67.2% of all the capital investment, the life sciences sector in Catalonia is showing the highest level of investment in Spain.